Sun Pharma Advanced Research Co. Ltd.Sun Pharma Advanced Research Co. Ltd.Sun Pharma Advanced Research Co. Ltd.

Sun Pharma Advanced Research Co. Ltd.

No trades
No trades

Compare with Sun Pharma Advanced Research Co. Ltd.


Market capitalization
‪61.24 B‬ INRSmall cap
48.82 INR
‪15.53 B‬ INR
‪18.79 B‬ INR
‪87.91 M‬
Beta (1Y)
1.89
Employees (FY)
466
Change (1Y)
−46−8.98%
Revenue / Employee (1Y)
‪40.33 M‬ INR
Net income / Employee (1Y)
‪33.33 M‬ INR

Company info


CEO
Anilkumar Raghavan
Website
Headquarters
Mumbai
Founded
2006
IPO date
Jul 18, 2007
ISIN
INE232I01014
FIGI
BBG000R3LTP9
Identifiers
ISIN INE232I01014
CFI code
ESVUFN
Sun Pharma Advanced Research Co. Ltd. is a bio-pharmaceutical company, which engages in the research and development of pharmaceuticals. It operates through the Within India and Outside India geographical segments. The company was founded on March 1, 2006, and is headquartered in Mumbai, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
Oscillators
Neutral
Summary
Neutral
Summary
Neutral
Summary
Neutral
Moving Averages
Neutral
Moving Averages
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


The current price of SPARC is 188.31 INR — it has increased by 1.46% in the past 24 hours. Watch Sun Pharma Advanced Research Co. Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange Sun Pharma Advanced Research Co. Ltd. stocks are traded under the ticker SPARC.
SPARC stock has fallen by −2.14% compared to the previous week, the month change is a −2.58% fall, over the last year Sun Pharma Advanced Research Co. Ltd. has showed a 44.30% increase.
SPARC reached its all-time high on Mar 10, 2015 with the price of 593.85 INR, and its all-time low was 35.16 INR and was reached on Dec 15, 2008. View more price dynamics on SPARC chart.
See other stocks reaching their highest and lowest prices.
SPARC stock is 3.34% volatile and has beta coefficient of 1.89. Track Sun Pharma Advanced Research Co. Ltd. stock price on the chart and check out the list of the most volatile stocks — is Sun Pharma Advanced Research Co. Ltd. there?
Today Sun Pharma Advanced Research Co. Ltd. has the market capitalization of ‪62.23 B‬, it has decreased by −0.23% over the last week.
Yes, you can track Sun Pharma Advanced Research Co. Ltd. financials in yearly and quarterly reports right on TradingView.
SPARC net income for the last quarter is ‪−207.80 M‬ INR, while the quarter before that showed ‪17.61 B‬ INR of net income which accounts for 0.00% change. Track more Sun Pharma Advanced Research Co. Ltd. financial stats to get the full picture.
No, SPARC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 15, 2026, the company has 466 employees. See our rating of the largest employees — is Sun Pharma Advanced Research Co. Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Sun Pharma Advanced Research Co. Ltd. EBITDA is ‪16.17 B‬ INR, and current EBITDA margin is 85.63%. See more stats in Sun Pharma Advanced Research Co. Ltd. financial statements.
Like other stocks, SPARC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sun Pharma Advanced Research Co. Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Sun Pharma Advanced Research Co. Ltd. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Sun Pharma Advanced Research Co. Ltd. stock shows the neutral signal. See more of Sun Pharma Advanced Research Co. Ltd. technicals for a more comprehensive analysis.